EP. 1: EYLEA’s unique MoA: What is the rationale for the higher molar dose?ByProfessor Jean-Francois Korobelnik, University Hospital of Bordeaux, FranceJanuary 23rd 2025
EP. 2: EYLEA 8mg in focus: Key learnings from the pivotal trialsByProfessor Varun Chaudhary, McMaster University, CanadaJune 5th 2025
EP. 3: Real World insights with EYLEA 8mgByDr Peter Kaiser, Cole Eye Institute, Cleveland Clinic, USAJuly 14th 2025
